COMBINATION THERAPY
A Combined Approach
Children need the best control methods to slow myopia progression - sometimes, mono-therapy is not enough.
This is where combining treatment options becomes appropriate & helpful in managing rapidly progressing myopia.
Atropine is easy to instill and versatile for use -this makes it a popular choice for combination therapy.
​
Atropine can be added to myopia control spectacle wear & myopia control contacts (soft lenses &/or orthokeratology).
​
It is not recommended to continue with atropine use with RLRL.
RLRL is a great option for combination therapy. It is non-invasive an as such it is suitable for younger children who may not be able to tolerate eye drops or contact lenses. It can also be monitored very closely which means compliance can be more readily asserted.
​
Several studies have shown that RLRL has stronger therapeutic effects with orthokeratology than orthokeratology alone. Studies have also verified it's use alongside MiSight contact lenses and Miyosmart glasses
A flexible, combined approach to myopia control can also be adopted. This is frequently the case as we aim to fit our treatment modalities to suit your child's lifestyle and visual needs. This may mean that your child has a primary treatment option and supplementary adjunct treatments to compliment their day-to-day tasks, hobbies and/or vision preferences.
When Would Combination Therapy Be Appropriate?
When a child's axial length, &/or prescription, is progressing beyond expected measures while on mono-therapy
If a child's risk factors are high - this includes parental history of myopia, close working demands or early onset of high myopia
When it becomes apparent after a few months of reviews on mono-therapy that more rapid changes are occurring despite excellent compliance